Amgen believes that it can transcend the expected tradeoff between convenience and efficacy, anticipating that its ...

Amgen AMGN reported fourth-quarter 2025 adjusted earnings of $5.29 per share, which beat the Zacks Consensus Estimate of ...

Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar ...

The stock market is divided, with the Nasdaq and S&P 500 breaking support but many sectors thriving. Google and Amazon AI ...

Good afternoon, everyone, and welcome to our fourth quarter 2025 earnings call. Bob Bradway will lead the call today and be followed by a broader review of our performance by Jay Bradner, Murdo Gordon ...

Big Pharma delivered strong Q4 2025 results, with most companies beating revenue and EPS expectations and providing generally solid 2026 guidance. Eli Lilly solidified its leadership in obesity and ...

In its first financial results announcement after the spin-off, Samsung Bioepis recorded FY2025 revenue of KRW 1.672 trillion, highest annual revenue in its 14-year history Excluding milestone ...

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

In patients experiencing refractory ischemic digital complications from systemic sclerosis or other diseases, BTX injections are safe and effective.

In this interview, law professor Corinna Barrett Lain discusses her book 'Secrets of the Killing State,' which exposes the ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

For the entirety of the regular season, New England Patriots quarterback Drake Maye played like an MVP frontrunner — and he ...